Angiogenic factors and pre-eclampsia: An early marker is needed

Clinical Science

Volumn 116, Issue 3, 2009, Pages 231-232

  Stepan, Holger ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

Angiogenesis; Plasma marker; Pre eclampsia; Splice variant; Vascular endothelial growth factor 165b (VEGF165b); Vascular permeability

Indexed keywords

ANGIOGENIC FACTOR; ENDOGLIN; MESSENGER RNA PRECURSOR; PLACENTAL GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA3; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN RECEPTOR 1; BIOLOGICAL MARKER; PLACENTA PROTEIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

DIAGNOSTIC VALUE; DISEASE MARKER; ENDOTHELIAL DYSFUNCTION; HUMAN; INFLAMMATION; NOTE; OXIDATIVE STRESS; PATHOGENESIS; PREDICTION; PREECLAMPSIA; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SIGNAL TRANSDUCTION; UPREGULATION; BLOOD; EARLY DIAGNOSIS; FEMALE; PREGNANCY;

ANGIOGENESIS INDUCING AGENTS; BIOLOGICAL MARKERS; EARLY DIAGNOSIS; FEMALE; HUMANS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 60549087158     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20080598     Document Type: Note

References (10)

1. Sibai, B., Dekker, G. and Kupferminc, M. (2005) Pre-eclampsia. Lancet 365, 785-799
2. Maynard, S. E., Min, J. Y., Merchan, J. et al. (2003) Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 111, 649-658
3. Lam, C., Lim, K. H. and Karumanchi, S. A. (2005) Circulating angiogenic factors in the pathogenesis and prediction of preeclampsia. Hypertension 46, 1077-1085
4. Levine, R. J. and Karumanchi, S. A. (2005) Circulating angiogenic factors in preeclampsia. Clin. Obstet. Gynecol. 48, 372-386
5. Levine, R. J., Maynard, S. E., Qian, C. et al. (2004) Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 350, 672-683
6. Venkatesha, S., Toporsian, M., Lam, C. et al. (2006) Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat. Med. 12, 642-649
7. Levine, R. J., Lam, C., Qian, C. et al. (2006) Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N. Engl. J. Med. 355, 992-1005
8. 165b in maternal plasma is a first trimester predictive marker for pre-eclampsia. Clin. Sci. 116, 265-272
9. Vatten, L. J., Eskild, A., Nilsen, T. I., Jeansson, S., Jenum, P. A. and Staff, A. C. (2007) Changes in circulating level of angiogenic factors from the first to second trimester as predictors of preeclampsia. Am. J. Obstet. Gynecol. 196, 239.e1-e6
10. Rana, S., Karumanchi, S. A., Levine, R. J. et al. (2007) Sequential changes in antiangiogenic factors in early pregnancy and risk of developing preeclampsia. Hypertension 50, 35-36